adyn

Seattle, United States Founded: 2019 • Age: 7 yrs
Provider of DNA and hormone analysis based birth control optimization kits

About adyn

adyn is a company based in Seattle (United States) founded in 2019. adyn has raised $2.65 million across 2 funding rounds from investors including Lux Capital, M13 Company and Civilization Ventures. adyn offers products and services including Birth Control Test and Quiz and Consultation. adyn operates in a competitive market with competitors including Strand Life Sciences, Invitae, Genome Medical, Myriad Genetics and Fulgent Genetics, among others.

Key Metrics
  • Total Equity Funding
    $2.65M (USD)

    in 2 rounds

  • Latest Funding Round
    $2.5M (USD), Seed

    Apr 2021

  • Investors
    Lux Capital

    & 10 more

Products & Services of adyn

adyn offers a comprehensive portfolio of products and services, including Birth Control Test and Quiz and Consultation.

Birth Control Test
Health Testing

At-home kit for analyzing hormones and genetics to recommend side-effect-free birth control.

Quiz and Consultation
Health Advisory

Interactive quiz providing personalized birth control recommendations and virtual provider visits.

Funding Insights of adyn

adyn has successfully raised a total of $2.65M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2.5 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $2.65M
  • Total Rounds 2
  • Last Round Seed β€” $2.5M
  • First Round $150,000

    (Aug 2020)

  • Investors Count 11

All 2 funding rounds of adyn with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2021$2.5MSeed–Lux Capital, M13 Company
Aug 2020$150,000Seed–Y Combinator
–
Valuation history

11 investors in total: 7 institutional and 4 angel.

Investors in adyn

adyn has secured backing from 11 investors, including venture fund and angel investors. Prominent investors backing the company include Lux Capital, M13 Company and Civilization Ventures.

All
Venture Fund
Angel
InvestorDescriptionFounded YearDomainLocation
Seed and early-stage technology companies are funded by Lux Capital.
–luxcapital.comMenlo Park, United States
Multiple sectors are invested in by M13 venture capital fund.
–m13.coLos Angeles, United States
Venture capital is provided to health tech and biology innovations.
–civilizationventures.comSan Francisco, United States
Financial and social capital is invested in visionary ventures.
–concreterosecapital.comSan Francisco, United States
Early-stage startups are accelerated via funding and educational programs.
–ycombinator.comMountain View, United States
Ascend is recognized as a pre-seed venture capital fund based in the Pacific Northwest.
–ascend.vcSeattle, United States
Venture capital investing in AI, biotech, and technology sectors, focusing on seed and early stages in Seattle and beyond.
–madrona.com-

Anne Wojcicki

Co-founder of 23andMe, prominent angel investor in health tech.
–unknown_fee74e3dede64052a-

Nish Bhat

Angel investor and entrepreneur, co-founder of 91springboard, focused on startups
–unknown_3fef05b77ae240aab-

Qasar Younis

Angel investor, ex-Y Combinator partner, focused on tech startups
–unknown_68532f40a1fc477e8-
Premium access

Investor details for adyn

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of adyn

1 people are tracked at adyn (1 in leadership).

NameRoleGroup
Elizabeth Ruzzo
Founder & CEOLeadership
Premium access

Complete people profiles for adyn

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of adyn

3 dated milestones of adyn across 2 years, from founding to its latest funding, stage changes and deals.

  1. Founded adyn is founded.
  2. Funding First funding round of $150K.
  3. Funding Latest funding round, Seed, of $2.5M.

Competitors of adyn

adyn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Strand Life Sciences, Invitae, Genome Medical, Myriad Genetics and Fulgent Genetics, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
strandls.com2000Bengaluru, India$34.88M532
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
invitae.com2010San Francisco, United States$189.56M1,700
Home-based genetic tests for detecting diseases are provided to individuals.
genomemedical.com2016Monterey, United States$172.98M84
Genomic testing services are provided clinically and directly to consumers.
myriad.com1991United States–2,700
Molecular diagnostics and personalized medicine for cancer are developed.
fulgentgenetics.com2011Temple, United States$64.25M591
Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer
anchordx.com2015Guangzhou, China$73M–
High-throughput gene sequencing platform is developed for clinical diagnostics.
centogene.com2006Rostock, Germany$28.02M657
Provider of biochemical/genetic tests to detect mutations and rare diseases
celmatix.com2009New York, United States$24.89M27
Fertility decisions are optimized using data analytics and genomics.
blueprintgenetics.com2012Espoo, Finland$19.86M–
Genetic diagnostics and clinical interpretation for hereditary diseases are provided.
circledna.com2014Hong Kong, China$15M–
Internet-first platform for genetic diagnostics is provided.
Premium access

Detailed competitors of adyn

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of adyn

The website of adyn (adyn.com) receives about 16.7K visits a month.

  • Monthly visits
    16.7K

    ▲ 20.4% vs previous month

Similar websites

Websites whose visitors overlap most with adyn. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
elcaminowomen.com
elcaminowomen.com
100%
–#1,583,021–
ijrcog.org
ijrcog.org
97%
–#544,897–
ellaone.co.uk
ellaone.co.uk
95%
–#759,899–
larabriden.com
larabriden.com
95%
–#551,246–
islandsexualhealth.org
76%
–#2,168,967View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 10 similar websites and full traffic analytics for adyn

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 10 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Adyn

Premium access

Complete news archive for adyn

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to adyn

10 companies that operate in the same segment as adyn (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M2,020
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 3.22 BUSD 147.17 M1,000
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M265
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Provider of an online genealogy platform offering a host of services
1996Lehi, Utah, United StatesUSD 146.2 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about adyn

adyn was founded in 2019 and raised its 1st funding round 1 year after it was founded.

adyn is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.

adyn is a funded company, having raised a total of $2.65M across 2 funding rounds to date. The company's 1st funding round was a Seed of $150K, raised on Aug 2020.

Provider of DNA and hormone analysis-based birth control optimization kits. The company offers collection kits (DNA sample and hormone sample), in which users can collect the sample as directed and the company offers an online personalized questionnaire for personal details for hormonal and genetic profile analysis to generate customized birth control recommendations which are further reviewed by a physician and delivered via data servers. The report also offers the medical biography with the side effect profiles, the company also offers the analysis of genetic predisposition, 4 synthetic estrogens, and 12 synthetic progestins.

adyn's top competitors include Strand Life Sciences, Fulgent Genetics and Centogene.

adyn offers Birth Control Test and Quiz and Consultation.

adyn has 11 investors. Key investors include Lux Capital, M13 Company, Civilization Ventures, Westbound, and Y Combinator.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available